Comparing two arsenic trioxide administration methods in APL therapy.
- Author:
Jin ZHOU
1
;
Ran MENG
;
Bao-feng YANG
Author Information
1. Hematology Division, The First Clinical Medical College of Harbin Medical University, Harbin 150001, China. Jinzhouh85@163.com
- Publication Type:Clinical Trial
- MeSH:
Antineoplastic Agents;
therapeutic use;
Arsenicals;
adverse effects;
therapeutic use;
Humans;
Leukemia, Promyelocytic, Acute;
drug therapy;
Leukocytosis;
chemically induced;
Oxides;
adverse effects;
therapeutic use
- From:
Chinese Medical Journal
2004;117(9):1411-1413
- CountryChina
- Language:English
